| From triazolophthalazines to triazoloquinazolines: A bioisosterism-guided approach toward the identification of novel PCAF inhibitors with potential anticancer activity MH El-Shershaby, A Ghiaty, AH Bayoumi, AA Al-Karmalawy, ... Bioorganic & Medicinal Chemistry 42, 116266, 2021 | 59 | 2021 |
| Investigating the Antibacterial Activity of Biphenylthiazoles against Methicillin- and Vancomycin-Resistant Staphylococcus aureus (MRSA and VRSA) M Hagras, H Mohammad, MS Mandour, YA Hegazy, A Ghiaty, ... Journal of Medicinal Chemistry 60 (9), 4074-4085, 2017 | 49 | 2017 |
| Novel triazolophthalazine-hydrazone hybrids as potential PCAF inhibitors: Design, synthesis, in vitro anticancer evaluation, apoptosis, and molecular docking studies HS Abulkhair, A Turky, A Ghiaty, HEA Ahmed, AH Bayoumi Bioorganic Chemistry 100, 103899, 2020 | 48 | 2020 |
| Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA) MM Elsebaei, H Mohammad, M Abouf, NS Abutaleb, YA Hegazy, A Ghiaty, ... European journal of medicinal chemistry 148, 195-209, 2018 | 46 | 2018 |
| Design, synthesis, and antitumor activity of novel compounds based on 1, 2, 4-triazolophthalazine scaffold: apoptosis-inductive and PCAF-inhibitory effects A Turky, AH Bayoumi, A Ghiaty, AS El-Azab, AM Alaa, HS Abulkhair Bioorganic Chemistry 101, 104019, 2020 | 45 | 2020 |
| Phenylthiazoles with tert-Butyl side chain: Metabolically stable with anti-biofilm activity A Kotb, NS Abutaleb, MA Seleem, M Hagras, H Mohammad, A Bayoumi, ... European journal of medicinal chemistry 151, 110-120, 2018 | 45 | 2018 |
| Synthesis and Evaluation of Some New (1, 2, 4) Triazolo (4, 3‐a) Quinoxalin‐4 (5H)‐one Derivatives as AMPA Receptor Antagonists H Abul‐Khair, S Elmeligie, A Bayoumi, A Ghiaty, A El‐Morsy, MH Hassan Journal of Heterocyclic Chemistry 50 (5), 1202-1208, 2013 | 43 | 2013 |
| Synthesis and Biological Evaluation of Some [1,2,4]Triazolo[4,3‐a]quinoxaline Derivatives as Novel Anticonvulsant Agents M Alswah, A Ghiaty, A El-Morsy, K El-Gamal International Scholarly Research Notices 2013 (1), 587054, 2013 | 43 | 2013 |
| 1, 2, 4-Triazolo [4, 3-c] quinazolines: a bioisosterism-guided approach towards the development of novel PCAF inhibitors with potential anticancer activity MH El-Shershaby, A Ghiaty, AH Bayoumi, HEA Ahmed, MS El-Zoghbi, ... New Journal of Chemistry 45 (25), 11136-11152, 2021 | 42 | 2021 |
| In vivo‐and in silico‐driven identification of novel synthetic quinoxalines as anticonvulsants and AMPA inhibitors HS Abulkhair, S Elmeligie, A Ghiaty, A El‐Morsy, AH Bayoumi, ... Archiv der Pharmazie 354 (5), 2000449, 2021 | 38 | 2021 |
| Design, synthesis, and molecular modelling of pyridazinone and phthalazinone derivatives as protein kinases inhibitors M Elagawany, MA Ibrahim, HEA Ahmed, AS El-Etrawy, A Ghiaty, ... Bioorganic & medicinal chemistry letters 23 (7), 2007-2013, 2013 | 38 | 2013 |
| Design, synthesis, and molecular docking studies of new [1,2,4]triazolo[4,3-a]quinoxaline derivatives as potential A2B receptor antagonists HG Ezzat, AH Bayoumi, FF Sherbiny, AM El-Morsy, A Ghiaty, M Alswah, ... Molecular Diversity 25, 291-306, 2021 | 37 | 2021 |
| Antimicrobial screening and pharmacokinetic profiling of novel phenyl-[1, 2, 4] triazolo [4, 3-a] quinoxaline analogues targeting DHFR and E. coli DNA gyrase B AM Omar, M Alswah, HEA Ahmed, AH Bayoumi, KM El-Gamal, A El-Morsy, ... Bioorganic chemistry 96, 103656, 2020 | 30 | 2020 |
| Biphenylthiazole antibiotics with an oxadiazole linker: An approach to improve physicochemical properties and oral bioavailability M Hagras, YA Hegazy, AH Elkabbany, H Mohammad, A Ghiaty, ... European journal of medicinal chemistry 143, 1448-1456, 2018 | 30 | 2018 |
| 4-Substituted benzenesulfonamides featuring cyclic imides moieties exhibit potent and isoform-selective carbonic anhydrase II/IX inhibition AM Alaa, AS El-Azab, AH Ghiaty, P Gratteri, CT Supuran, A Nocentini Bioorganic Chemistry 83, 198-204, 2019 | 28 | 2019 |
| tert-Butylphenylthiazoles with an oxadiazole linker: a novel orally bioavailable class of antibiotics exhibiting antibiofilm activity A Kotb, NS Abutaleb, M Hagras, A Bayoumi, MM Moustafa, A Ghiaty, ... RSC advances 9 (12), 6770-6778, 2019 | 22 | 2019 |
| Synthesis and evaluation of some new 1, 2, 4-triazolo (4, 3-a) quinoxalin-4-5H-one derivatives as AMPA receptor antagonists A Bayoumi, A Ghiaty, A El-Morsy, H Abul-Khair, MH Hassan, S Elmeligie Bulletin of Faculty of Pharmacy, Cairo University 50 (2), 141-146, 2012 | 22 | 2012 |
| Exploration of quinoxaline derivatives as antimicrobial and anticancer agents AH Bayoumi, AH Ghiaty, SM Abd El‐Gilil, EM Husseiny, MA Ebrahim Journal of Heterocyclic Chemistry 56 (12), 3215-3235, 2019 | 20 | 2019 |
| Synthesis and biological evaluation of some quinoxaline-2-one derivatives as novel anticonvulsant agents E Elkaeed, A Ghiaty, A El-Morsy, K El-Gamal, H Sak Chem Sci Rev Lett 3 (12), 1375-1387, 2014 | 14 | 2014 |
| Azab, AA‐M. Abdel‐Aziz, HS Abulkhair A Turky, AH Bayoumi, A Ghiaty, AS El Bioorg. Chem 101, 104019, 2020 | 9 | 2020 |